Rubinstein E - Search Results

1

Intracellular survival of persistent group A streptococci in cultured epithelial cells.

Marouni MJ, Barzilai A, Keller N, Rubinstein E, Sela S. Marouni MJ, et al. Among authors: rubinstein e. Int J Med Microbiol. 2004 Jul;294(1):27-33. doi: 10.1016/j.ijmm.2004.01.001. Int J Med Microbiol. 2004. PMID: 15293451

2

The susceptibility of Streptococcus pneumoniae to levofloxacin and other antibiotics.

Keller N, Smollen G, Davidson Y, Barzilai A, Keren G, Rubinstein E. Keller N, et al. Among authors: rubinstein e. J Antimicrob Chemother. 1999 Jun;43 Suppl C:1-3. doi: 10.1093/jac/43.suppl_3.1. J Antimicrob Chemother. 1999. PMID: 10404329

3

Spiramycin renaissance.

Rubinstein E, Keller N. Rubinstein E, et al. J Antimicrob Chemother. 1998 Nov;42(5):572-6. doi: 10.1093/jac/42.5.572. J Antimicrob Chemother. 1998. PMID: 9848439 Review. No abstract available.

4

Future prospects and therapeutic potential of streptogramins.

Rubinstein E, Keller N. Rubinstein E, et al. Drugs. 1996;51 Suppl 1:38-42. doi: 10.2165/00003495-199600511-00008. Drugs. 1996. PMID: 8724815 Review.

5

The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.

Rubinstein E, Diamantstein L, Yoseph G, Gruzman G, Rubinovitch B, Barzilai A, Keller N. Rubinstein E, et al. Clin Microbiol Infect. 2000 Dec;6(12):678-81. doi: 10.1046/j.1469-0691.2000.00166.x. Clin Microbiol Infect. 2000. PMID: 11284929 Free article. No abstract available.

6

Sepsis caused by sulfamethoxazole-trimethoprim-resistant pneumococci.

Keren G, Barzilai A, Rubinstein E. Keren G, et al. Among authors: rubinstein e. Isr J Med Sci. 1987 Jul;23(7):835-6. Isr J Med Sci. 1987. PMID: 3500935 No abstract available.

7

Pefloxacin treatment of meningitis caused by gram-negative bacteria.

Segev S, Barzilai A, Rosen N, Joseph G, Rubinstein E. Segev S, et al. Among authors: rubinstein e. Arch Intern Med. 1989 Jun;149(6):1314-6. Arch Intern Med. 1989. PMID: 2730249

8

Effect of cholera toxin on intestinal elimination of ciprofloxacin in rabbits.

Musafija A, Barzilai A, Ramon J, Rubinstein E. Musafija A, et al. Among authors: rubinstein e. Antimicrob Agents Chemother. 1998 Feb;42(2):473-4. doi: 10.1128/AAC.42.2.473. Antimicrob Agents Chemother. 1998. PMID: 9527813 Free PMC article.

9

Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients.

Barzilai A, Rubinovich B, Blank-Porat D, Rubinstein E, Keller N, Levi I. Barzilai A, et al. Among authors: rubinstein e. Scand J Infect Dis. 1998;30(2):143-6. doi: 10.1080/003655498750003528. Scand J Infect Dis. 1998. PMID: 9730300

10

The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model.

Leibovitz E, Keren G, Shabtai M, Barzilai A, Rubinstein E. Leibovitz E, et al. Among authors: rubinstein e. J Antimicrob Chemother. 1989 Sep;24(3):375-85. doi: 10.1093/jac/24.3.375. J Antimicrob Chemother. 1989. PMID: 2509411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

774 results

Search Page

Filters